1. Home
  2. FRSX vs BRTX Comparison

FRSX vs BRTX Comparison

Compare FRSX & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$1.56

Market Cap

6.3M

Sector

Technology

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.17

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSX
BRTX
Founded
N/A
1997
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
9.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FRSX
BRTX
Price
$1.56
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
575.7K
33.2K
Earning Date
03-24-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$452,000.00
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
N/A
$139.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.70
52 Week Low
$1.52
$0.98
52 Week High
$18.41
$2.55

Technical Indicators

Market Signals
Indicator
FRSX
BRTX
Relative Strength Index (RSI) 31.46 48.30
Support Level $1.52 $1.04
Resistance Level $1.74 $1.23
Average True Range (ATR) 0.12 0.08
MACD -0.02 0.02
Stochastic Oscillator 12.00 69.57

Price Performance

Historical Comparison
FRSX
BRTX

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: